Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases

Figure 3

Change in health-related quality of life after treatment. Mean changes from baseline to the first assessment time point in Short Form Health Survey-36 (SF-36) scales for patients with rheumatoid arthritis (RA) (a; change from baseline to week 6 or 10), patients with psoriatic arthritis (PsA) (b; change from baseline to week 14), and patients with ankylosing spondylitis (AS) (c; change from baseline to week 12). BP, bodily pain; GH, general health; MCS, mental component summary score; MH, mental health; PCS, physical component summary score; PF, physical functioning; RE, role emotional; RP, role physical; SF, social functioning; VT, vitality.

Back to article page